IndraLab

Statements

Hydroxychloroquine inhibits disease flares. 3 / 3
| 3
eidos
"Although initially used predominantly for RA , HCQ may be most efficacious in SLE , for which besides treating skin and joint disease , HCQ prevents disease flares , promotes long-term survival , and improves overall prognosis [ 17 ] ."
33095083
eidos
"Hydroxychloroquine is commonly used in the management of SLE to prevent disease flares and to treat mild disease activity , and it has also been shown to have antithrombotic and lipid-lowering properties39 ."
32968109
eidos
"Chloroquine and hydroxychloroquine are approved for the treatment of SLE and have been shown to reduce the frequency of disease flares ( particularly of lupus nephritis ) , contribute to the maintenance of remission , prolong the onset of disease and reduce the risk of complications.1 ,2,3,4,5 Beyond their immunomodulatory effects in SLE , these agents have also been shown to protect against thrombotic events ,2 improve glucose and lipid profiles , and prevent renal damage ,6 apparently resulting in reduced cardiovascular risk , for which SLE is an independent risk factor ."
20046202